Vaccine

Just 27 percent of Americans said they trust the president to provide them with accurate information about COVID-19.

The president told South Korean President Moon Jae-in Monday he would visit Seoul after being vaccinated with the new treatment.

"We encourage Americans to enroll in the vaccine trial," President Donald Trump said during a Thursday press conference.

Dr. Robert Redfield joined other top health officials in testifying in front of the Senate Committee on Health, Education, Labor and Pensions to discuss federal response to the coronavirus pandemic.

Unlike the other vaccine candidates that require two doses, the Johnson & Johnson vaccine is a single-dose, which may make it easier to distribute.

A majority of Americans are also concerned that President Trump is trying to get a vaccine released too quickly to bolster his re-election chances.

An overwhelming majority of Americans have no confidence or trust in President Donald Trump to verify the safety of any coronavirus vaccine, a new poll shows.

The speed at which a new coronavirus vaccine is being developed stoked concerns about its safety, but FDA Commissioner Dr. Stephen Hahn said there would be "no cutting corners."

The White House chief of staff told reporters that Dr. Robert Redfield's vaccine timeline "is not consistent with what I have had personal interaction with."

Dozens of vaccines for COVID-19 are currently in human clinical trials, with a small number already approved for limited use— however, none have reached the final stage of research proving they are safe and effective.

"They're recklessly endangering lives," President Donald Trump said on Wednesday. "You can't do that."

Democratic presidential candidate Joe Biden claims President Donald Trump could be rushing the development of a COVID-19 vaccine to score political points in the November election, while Trump's allies are accusing Biden of promoting "anti-vaccine conspiracy theories."

Among those who voted for Trump in 2016, a quarter agree that he is no longer fighting hard to stop the spread of COVID-19.

Since August 26 I have been running trials of a vaccine for COVID-19. Towards the end of the year I think it will be possible to have early indicators as to how effective this vaccine is and whether it can be submitted for FDA approval.

Although the three have offered similar timelines, Facui's taken the most conservative approach, saying a vaccine likely won't be available before the end of the year.

Scientists will test the Oxford vaccine and another being developed by scientists at Imperial College London.

Americans want a COVID-19 vaccine—but worry that it could be rushed out before the election. Here's what the science says.

In a Newsweek interview, Fauci says a presidential edict to force the FDA to approve an expedited COVID-19 vaccine before Election Day would never fly.

Professor Grant McFadden of Arizona State University told Newsweek "disinformation and outright lies" circulate widely.

AstraZeneca said illnesses will happen by chance in trials and must be independently reviewed.

Dr. James Gill of Warwick Medical School said the decision "should be championed as good science and great transparency."

"This is a vaccine that we're going to have very soon," the president said. "By the end of the year. But much sooner than that perhaps."

Phase 3 trials for AstraZeneca's COVID-19 vaccine candidate were paused Tuesday due to a "potentially unexplained illness in one of the trials."

It's unlikely a vaccine could be considered safe and effective by Election Day, but Dr. Anthony Fauci said it's not impossible.

A recent peer-reviewed study shows that Russia's vaccine creates an immune response with no negative side effects.

"I think most of the people feel it's gonna be November-December," the director of the National Institute of Allergy and Infectious Diseases said.

As the race for a safe, effective vaccine to protect against COVID-19 continues across the globe, three candidates are currently undergoing late-stage clinical trials involving human participants.

The global average of adults saying they'd get vaccinated was 74 percent, versus 67 percent in the U.S.

Findings show which groups are more reluctant to get vaccinated, and the states with the highest and lowest adoption.

Diplomatic tensions may have set back Canadian efforts to develop a COVID-19 vaccine by months, as China continues disputes with both Canada and its neighbor the United States.